#VisualAbstract: Teprotumumab for the Treatment of Active Thyroid Eye Disease
1. In this phase 3 trial, patients with thyroid eye disease who received teprotumumab were far more likely to demonstrate ...
Tag: Graves’ Eye Disease
Teprotumumab may significantly improve outcomes in patients with active thyroid eye disease
1. In this phase 3 trial, patients with thyroid eye disease who received teprotumumab were far more likely to demonstrate ...
Patient Basics: Graves’ Eye Disease (Graves’ Ophthalmopathy)
Originally published by Harvard Health. What Is It? Graves' eye disease, also called Graves' ophthalmopathy, is a problem that develops ...
